Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness.
Sonzini G, Granados-Aparici S, Sanegre S, Diaz-Lagares A, Diaz-Martin J, de Andrea C, Eritja N, Bao-Caamano A, Costa-Fraga N, García-Ros D, Salguero-Aranda C, Davidson B, López-López R, Melero I, Navarro S, Ramon Y Cajal S, de Alava E, Matias-Guiu X, Noguera R. Sonzini G, et al. Among authors: de alava e, de andrea c. Front Cell Dev Biol. 2022 Nov 18;10:1052098. doi: 10.3389/fcell.2022.1052098. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36467415 Free PMC article.
High-Throughput Hybridization Assay as First-Line Diagnostic Test for Sarcomas: Clinical Assessment in a Tertiary Referral Center.
Salguero-Aranda C, Perez M, Vargas-Padilla MV, Beltrán-Povea A, Delgado-Bellido D, Marcilla D, Civantos G, de Álava E, Díaz-Martín J. Salguero-Aranda C, et al. Among authors: de alava e. Arch Pathol Lab Med. 2024 Oct 10. doi: 10.5858/arpa.2024-0202-OA. Online ahead of print. Arch Pathol Lab Med. 2024. PMID: 39384185 Free article.
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl).
Palmerini E, Gambarotti M, Italiano A, Nathenson MJ, Ratan R, Dileo P, Provenzano S, Jones RL, DuBois SG, Martin-Broto J, de Alava E, Baldi GG, Grignani G, Ferraresi V, Brunello A, Paoluzzi L, Bertulli R, Hindi N, Montemurro M, Rothermundt C, Cocchi S, Salguero-Aranda C, Donati D, Martin JD, Abdelhamid Ahmed AH, Mazzocca A, Carretta E, Cesari M, Pierini M, Righi A, Sbaraglia M, Laginestra MA, Scotlandi K, Dei Tos AP, Ibrahim T, Stacchiotti S, Vincenzi B. Palmerini E, et al. Among authors: de alava e. Eur J Cancer. 2023 Apr;183:11-23. doi: 10.1016/j.ejca.2023.01.003. Epub 2023 Jan 18. Eur J Cancer. 2023. PMID: 36791667
Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections.
Ruiz-Cáceres I, Hermida Romero T, Guerra Merino I, Portu Zapirain J, Pérez-Mies B, Sánchez-Conde M, Riaño MA, Rubio R, Fortés Alen J, Vidal González Á, Salas Antón C, Múñez E, Sánchez Sánchez R, Corona-Mata D, Aldecoa Ansorregui I, Miró JM, Beloqui Pérez de Obanos R, Ibero C, Gómez-Román J, Fariñas MC, Tabuyo Bello T, de Alava E, Cisneros JM, Matías-Guiu X, Rivero A; NECROCOVID Study Group. Ruiz-Cáceres I, et al. Among authors: de alava e. Front Med (Lausanne). 2023 Jul 4;10:1151843. doi: 10.3389/fmed.2023.1151843. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37484846 Free PMC article.
Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS).
Pérez-Fidalgo JA, Ortega E, Ponce J, Redondo A, Sevilla I, Valverde C, Isern Verdum J, de Alava E, Galera López M, Marquina G, Sebio A. Pérez-Fidalgo JA, et al. Among authors: de alava e. Ther Adv Med Oncol. 2023 Mar 28;15:17588359231157645. doi: 10.1177/17588359231157645. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37007636 Free PMC article. Review.
Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma.
Pascual-Pasto G, Resa-Pares C, Castillo-Ecija H, Aschero R, Baulenas-Farres M, Vila-Ubach M, Burgueño V, Balaguer-Lluna L, Cuadrado-Vilanova M, Olaciregui NG, Martinez-Velasco N, Perez-Jaume S, de Alava E, Tirado OM, Lavarino C, Mora J, Carcaboso AM. Pascual-Pasto G, et al. Among authors: de alava e. Biochem Pharmacol. 2023 Feb;208:115408. doi: 10.1016/j.bcp.2022.115408. Epub 2023 Jan 2. Biochem Pharmacol. 2023. PMID: 36603685
Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology.
Ilié M, Lake V, de Alava E, Bonin S, Chlebowski S, Delort A, Dequeker E, Al-Dieri R, Diepstra A, Carpén O, Eloy C, Fassina A, Fend F, Fernandez PL, Gorkiewicz G, Heeke S, Henrique R, Hoefler G, Huertas P, Hummel M, Kashofer K, van der Laak J, de Pablos RM, Schmitt F, Schuuring E, Stanta G, Timens W, Westphalen B, Hofman P. Ilié M, et al. Among authors: de alava e. Virchows Arch. 2024 Nov;485(5):761-775. doi: 10.1007/s00428-024-03933-2. Epub 2024 Oct 2. Virchows Arch. 2024. PMID: 39354109 Review.
Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS).
Mata Fernández C, Sebio A, Orcajo Rincón J, Martín Broto J, Martín Benlloch A, Marcilla Plaza D, López Pousa A, Gracia Alegría I, Giuppi M, Collado Ballesteros E, Bernabeu D, de Alava E, Valverde Morales C. Mata Fernández C, et al. Among authors: de alava e. Clin Transl Oncol. 2024 Aug 19. doi: 10.1007/s12094-024-03602-5. Online ahead of print. Clin Transl Oncol. 2024. PMID: 39158802 Review.
214 results